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A 16S rRNA-targeted probe, MUC-1437, was designed and validated in order to determine the presence and
numbers of cells of Akkermansia muciniphila, a mucin degrader, in the human intestinal tract. As determined
by fluorescent in situ hybridization, A. muciniphila accounted more than 1% of the total fecal cells and was
shown to be a common bacterial component of the human intestinal tract.
The human intestinal mucosal surfaces are exposed to an
enormous amount of bacteria; the concentrations approach
1014 organisms per individual and represent more than 1,000
species (14). This intestinal microbiota is thought to have
evolved in an alliance with its host, and this symbiotic relation-
ship is particularly relevant in the protective mucus layer that
covers the epithelium and consists of water-containing mucins
(1), which are high-molecular-weight glycoproteins, and other
host-encoded products. Mucus offers numerous ecological ad-
vantages to intestinal bacteria as it represents a direct source of
nutrients for these bacteria, especially in the colon, where
carbon sources are limited (15). By incorporating mucin in a
medium as a major carbon and energy source, we were able to
isolate a novel bacterium, Akkermansia muciniphila MucT (6),
that belongs to the Verrucomicrobia phylum, a recently recog-
nized division of the Bacteria (9). Analysis of the results ob-
tained for reported clone libraries generated from either feces
or biopsy samples showed that eight 16S rRNA sequences
showed levels of sequence similarity of 98% and three se-
quences showed 98% similarity with the 16S rRNA gene
sequence of A. muciniphila (Fig. 1), indicating that they might
represent other species in the genus Akkermansia. These se-
quences were derived from human clone libraries from healthy
individuals (7, 8, 10, 12, 17; K. Saunier et al., unpublished data)
and biopsies of inflammatory bowel disease patients (12; R. A.
Hutson and M. D. Collins, unpublished data), as well as ani-
mals, such as herbivores (13) and mice (16). In this study, we
designed, validated, and used a specific probe targeting the 16S
rRNA gene sequence of A. muciniphila in fecal samples from
healthy adults and babies to determine the prevalence and
proportion of this novel mucin-degrading bacterium using flu-
orescent in situ hybridization (FISH) combined with flow cy-
tometry.
Probe design and validation. Sequences of the 16S rRNA
genes of A. muciniphila and its closest relatives (Table 1) and
sequences of 96 intestinal 16S rRNA gene clones were aligned
using CLUSTAL-X and checked for regions with conserved
and variable sequences. Based on this alignment, a 16S rRNA
oligonucleotide probe targeting part of hypervariable region
V9 of the 16S rRNA gene sequence of A. muciniphila was
designed. A region corresponding to nucleotides 1437 to 1456
of Escherichia coli was chosen. The newly designed probe was
checked against the small-subunit rRNA database of the Ri-
bosomal Data Project II software package using the Probe
Match function (4), and a similarity search sequence of the
NCBI database was performed with BLAST (www.ncbi.nlm
.nih.gov/BLAST). The probe was designated S-St-Muc-1437-a-
A-20 (MUC-1437) based on the nomenclature of the Oligo-
nucleotide Probe Database (2) and had the following
sequence: 5-CCTTGCGGTTGGCTTCAGAT-3. The oligo-
nucleotide probe sequence has been deposited in probeBase
(11). All oligonucleotide probes were purchased from Thermo
Electron (Ulm, Germany) and were double labeled at both the
5 and 3 ends with Cy5, Cy3, or fluorescein isothiocyanate.
The EUB-338 probe (5-GCTGCCTCCCGTAGGAGT-3)
was used as the positive control (3), and the NON-EUB probe
(5-ACATCCTACGGGAGGC-3) was used as a negative
control to monitor nonspecific binding (18). EUB-338 or
the nucleic acid stain TOTO-1 iodide (Invitrogen, Leiden, The
Netherlands) was used for total bacterial and cell counting.
TOTO-1 is a membrane-impermeant nucleic acid with very
high fluorescence enhancement and quantum yield when it
binds to the nucleic acids of a cell. Fifty bacterial strains be-
longing to the genera Atopobium, Bacteroides, Bifidobacterium,
Clostridium, Colinsella, Coprococcus, Enterococcus, Esche-
richia, Eubacterium, Faecalibacterium, Lachnospira, Lactobacil-
lus, Megasphaera, Mitsuokella, Peptostreptococcus, Prevotella,
Roseburia, Ruminococcus, Streptococcus, Veillonella, and Victi-
vallis (5) were used for optimization and validation of the FISH
probe. The hybridization conditions for MUC-1437 with A.
muciniphila were optimized by increasing the concentration of
formamide in the hybridization buffer as described by Zoeten-
dal et al. (19). To quantify hybridized cells, samples were
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analyzed using a FACSCalibur flow cytometer (Becton Dick-
inson Immunocytometry Systems, San Jose, CA) equipped
with an air-cooled argon ion laser providing 15 mW at 488 nm
combined with a 670-nm red-diode laser with the standard
filter setup. For total cell enumeration, samples were incu-
bated in the presence of 1 nM TOTO-1 (Molecular Probes,
Leiden, The Netherlands) for 5 min at room temperature.
Unlabeled beads (diameter, 6.0 m) provided with a bacterial
counting kit (Molecular Probes BV, Leiden, The Netherlands)
were added to each sample stained with TOTO-1 at a final
concentration of 106 beads/ml and were used as an internal stan-
dard to calibrate the sample volume. The relative abundance
(proportion) of A. muciniphila-like bacteria was estimated by
determining the ratio of the number of cells hybridized with
Cy5-labeled MUC-1437 to the number of TOTO-1-stained
cells. The analysis was performed using the WinMDI version
2.8 software (http://facs.scripps.edu/software.html) or the
CellQuest Pro program (Becton Dickinson Immunocytometry
Systems, San Jose, CA).
Optimal discrimination between the 50 strains (5) and A.
muciniphila was achieved using a formamide concentration of
20%, and under these conditions none of the nontarget organ-
isms showed cross-hybridization with the MUC-1437–Cy5
probe (data not shown). Hence, these conditions were consid-
ered specific for A. muciniphila in further FISH analysis of
fecal samples. Remarkably, when cells were hybridized to the
general bacterial probe EUB-338, the percentage of hybridized
cells was intermediate between the values for the NON-EUB
and MUC-1437 signals (see Fig. S1, panels A to C, in the
supplemental material). This could be explained by the two
mismatches between the sequences from the EUB-338 probe
and the corresponding region of the 16S rRNA sequence from
A. muciniphila. It is noteworthy that we also found in the 16S
rRNA sequence of A. muciniphila two mismatches with the
bacterial probe (EUB-338) commonly used as a positive con-
trol in FISH analysis, and A. muciniphila cells showed only a
weak signal after EUB-338 hybridization. In retrospect, this
suggests why A. muciniphila has not been identified previously.
Quantification of A. muciniphila in feces. Fresh fecal sam-
ples were collected from 50 Finnish babies who were 6 and 12
months old (25 females and 25 males), 13 healthy Dutch adults
(8 females and 5 males; ages, 26 to 40 years), and 13 Finnish
adults (all females; ages, 26 to 34 years). These volunteers had
not been subjected to any feeding trial, specific diet, or anti-
biotic treatment for the previous year. Samples were processed
immediately after collection, and fixed samples were hybrid-
ized in 20% (vol/vol) formamide buffer as described above. For
total cell enumeration, samples were incubated in the presence
of TOTO-1 iodide as described above. Paired and unpaired t
tests were used for statistical analysis of comparisons of the
numbers of A. muciniphila cells in fecal samples. Cytometric
dot plots obtained after staining with TOTO-1 and hybridiza-
tion with Cy5-labeled NON-EUB and MUC-1437 are shown in
Fig. S1, panels D to F, in the supplemental material. A. muci-
niphila cells (see Fig. S1, panel F, in the supplemental mate-
rial) were represented in the FL4 signal (Cy5 fluorescence) as
the black population separated from the nonhybridized cells
FIG. 1. Phylogenetic tree showing the position of A. muciniphila and the clone sequences in the Verrucomicrobia phylum. The numbers after
the commas are accession numbers. Bar  10% sequence divergence.
TABLE 1. Aligned sequences of the oligonucleotide probe and
the 16S rRNA gene sequences of the closest relatives of
A. muciniphila in the Verrucomicrobia phylum
Probe or target Sequencea
S-St-Muc-1437-a-A-20 .......................3 TAGACTTCGGTTGGCGTTCC 5
Akkermansia muciniphila...................5 ATCTGAAGCCAACCGCAAGG 3
Clones HuCA18 and HuCC13 .........5 ●●●●●●●●●●●●●●●●●●●● 3
Verrucomicrobium spinosum..............5 GC●C●C-●●●G●●●●●●●●● 3
Prosthecobacter dejongeii....................5 GCG●●●-●T●●●●●●●●●●● 3
Prosthecobacter vanneervenii..............5 GCG●●●-●T●●●●●●●●●●● 3
Prosthecobacter debontii .....................5 GCG●●●-●T●●●●●●●●●●● 3
Prosthecobacter fusiformis ..................5 GCG●●C-●●●●●●●●●●●●● 3
a Filled circles represent consensus with the A. muciniphila sequence; dashes
represent missing bases.
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(gray). The percentage of A. muciniphila in the 13 samples
from Dutch individuals was 92%, and this organism was clearly
detected in 12 of the samples. For these 12 subjects, dot plot
analysis based on the bead method resulted in a mean value of
1.26% 0.85% of the total fecal cells, corresponding to 8.24
108  7.35  108 cells g (wet weight)1. The level of A.
muciniphila cells ranged between the detection limit (0.1%)
and 3.08% of the total fecal cells and did not differ significantly
for male and female individuals (data not shown). Subse-
quently, A. muciniphila was also quantified using feces from 13
Finnish subjects. The results indicated that A. muciniphila
accounted for 1.32  109  1.50  109 cells g (wet weight)1
and represented 2.04%  0.90% of the total bacterial cells.
The differences between Dutch and Finnish individuals (Fig.
2) were found to be not significant (P  0.08). Feces from a
total of 50 6- and 12-month-old babies were used to quantify
A. muciniphila by FISH-flow cytometry using MUC-1437.
The concentration of A. muciniphila increased significantly
between 6 and 12 months (P  0.001) (Fig. 2), and the levels
of this organism were 1.41  108  3.23  108 and
4.92  108  4.20  108 cells g (wet weight) feces1 for the 6-
and 12-month-old babies, respectively, representing 0.86% 
1% and 1.56%  0.58% of the bacterial cells. These data
indicate that A. muciniphila colonizes the intestinal tract early
in life and that within 1 year the level is close to the level
observed in adults.
Perspectives. In conclusion, we describe for the first time
validation and application of a novel phylogenetic probe,
MUC-1437, targeting an intestinal organism. The data indicate
that the mucus-utilizing organism A. muciniphila colonizes
the intestinal tract early in life and that within 1 year the level
is close to the level observed in healthy adults, representing
approximately 1 to 3% of the total microbiota. The abundance
of A. muciniphila in the human intestine provides new perspec-
tives for further investigating its role in health and disease in
relation to mucin degradation.
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FIG. 2. Quantification of A. muciniphila (log cells/g [wet weight] of
feces) in feces from Finnish (F) babies and adults and Dutch
(D) adults, with the results represented by box and whisker plots. Each
box extends from the 25th percentile to the 75th percentile, and a line
indicates the median. The whiskers show the highest and lowest values
after exclusion of the outliers, which are represented by dots.
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